Extensive epidermal necrosis due to terlipressin

Israel Medical Association Journal

Volumn 13, Issue 3, 2011, Pages 180-181

  Yefet, Enav ^a   Gershovich, Maria ^a   Farber, Evgeni ^a   Soboh, Soboh ^a  

^a BARUCH PADEH MEDICAL CENTER   (Israel)

Author keywords

Cirrhosis; Posteterlipressin; Skin necrosis; Upper gastrointestinal bleeding

Indexed keywords

TERLIPRESSIN;

AGED; ARTICLE; ASCITES; CASE REPORT; DOSE RESPONSE; DRUG DOSE REDUCTION; EPIDERMOLYSIS; ERYTHROCYTE TRANSFUSION; HEMATEMESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERSPLENISM; LABORATORY DIAGNOSIS; MALE; MELENA; PANCYTOPENIA; PARACENTESIS; PORTAL HYPERTENSION; SKIN NECROSIS; UPPER GASTROINTESTINAL BLEEDING;

AGED; EPIDERMIS; ESOPHAGEAL AND GASTRIC VARICES; FATAL OUTCOME; HUMANS; HYPERTENSION, PORTAL; ISCHEMIA; LYPRESSIN; MALE; NECROSIS; SKIN; VASOCONSTRICTOR AGENTS;

EID: 79954508350     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Krag A, Borup T, Moller S, Bendtsen F. Efcacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. Adv Ter 2008; 25: 1105-1140.
2. Megarbane H, Barete S, Khosrotehrani K, et al. Two observations raising questions about risk factors of cutaneous necrosis induced by terlipressin (Glypressin). Dermatology 2009; 218: 334-337.
3. Donnellan F, Cullen G, Hegarty JE, McCormick PA. Ischaemic complications of Glypressin in liver disease: a case series. Br J Clin Pharmacol 2007; 64: 550-552.
4. Kam PC, Williams S, Yoong FF. Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia 2004; 59: 993-1001.
5. May G, Musa D. Best evidence topic report. The use of intravenous terlipressin in non-variceal upper GI bleeds. Emerg Med J 2006; 23: 400-401.